DJIA 16,014.38 -12.67 -0.08%
NASDAQ 4,268.76 -14.99 -0.35%
S&P 500 1,852.21 -1.23 -0.07%
market minute promo

4.28 -0.11 (-2.51%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SPPI $4.28 -2.51%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.28
Previous Close $4.39
Daily Range $4.14 - $4.52
52-Week Range $4.14 - $7.74
Market Cap $288.2M
P/E Ratio -5.78
Dividend (Yield) $0.00 (0.0%)
Volume 924,926
Average Daily Volume 819,277
Current FY EPS -$0.88

Sector

Healthcare

Industry

Drug Makers

Spectrum Pharmaceuticals, Inc. (SPPI) Description

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options. Website: http://www.sppirx.com/

News & Commentary Rss Feed

Here's Why Spectrum Pharmaceuticals' Stock Plunged Today

Spectrum Pharmaceuticals' stock drops after the company receives a dreaded CRL from the FDA for Evomela.

Ligand Pharmaceuticals (LGND): Q4 Earnings Preview

Spectrum (SPPI) Initiates Phase III Study on SPI-2012

Weak On High Volume: Spectrum Pharmaceuticals (SPPI)

Arbutus Biopharma Is Currently In Second Place In The Race For An HBV Cure

8-K Filings Shows Spectrum Pharma Signs Partnersship With Servier Canada, Will Receive $6M Upfront

Spectrum Pharmaceuticals and Onxeo Announce Complete Response in 67% of Patients with Peripheral T-C

Spectrum Pharmaceuticals and Onxeo Announce Complete Response in 67% of Patients with Peripheral T-Cell Lymphoma in Combination of Belinostat and Standard CHOP

US Stock Futures Signal Higher Start On Wall Street

Spectrum Pharmaceuticals Submits Phase 2 Breast Cancer Protocol to FDA as Part of an Investigational

Spectrum Pharmaceuticals Submits Phase 2 Breast Cancer Protocol to FDA as Part of an Investigational New Drug (IND) Application for Poziotinib

Spectrum (SPPI) Up on Selling Zevalin Rights to Mundipharma

Health Care Sector Update for 11/18/2015: PFE, SPPI, AVXL

See More SPPI News...

SPPI's Top Competitors

SPPI $4.28 (-2.51%)
Current stock: SPPI
NVS $72.62 (-0.77%)
Current stock: NVS
JNJ $101.97 (-0.03%)
Current stock: JNJ
RHHBY $31.14 (-0.35%)
Current stock: RHHBY